Scholar Rock Holding (SRRK) Revenue (2019 - 2022)
Scholar Rock Holding (SRRK) recorded quarterly Revenue of $33.2 million in Q1 2022, up 719.78% quarter-over-quarter from $4.0 million in Q4 2021, and up 605.03% on a YoY basis from $4.7 million in Q1 2021.
Scholar Rock Holding (SRRK) Revenue (2019 - 2022) Analysis & Trends
Scholar Rock Holding's Revenue history runs 4 years deep, the most recent figure standing at $33.2 million for Q1 2022.
- In Q1 2022, Revenue rose 605.03% year-over-year to $33.2 million; the TTM figure through Dec 2022 stood at $33.2 million (up 76.41% YoY), while the FY2022 annual figure was $33.2 million, up 76.41% from the prior year.
- Revenue was $33.2 million for Q1 2022 at Scholar Rock Holding, up from $4.0 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $33.2 million in Q1 2022 to a low of $3.0 million in Q3 2020.
- Historically, Revenue has averaged $6.8 million across 4 years, with a median of $4.7 million in 2021.
- The sharpest annual moves came in 2020 and 2022: Revenue tumbled 54.63% in 2020, then surged 605.03% in 2022.
- A 4-year view of Revenue shows it stood at $7.6 million in 2019, then sank by 54.63% to $3.4 million in 2020, then grew by 17.84% to $4.0 million in 2021, then surged by 719.78% to $33.2 million in 2022.
- The last three Revenue figures came in at $33.2 million (Q1 2022), $4.0 million (Q4 2021), and $5.5 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 33.19 Mn |
| Dec 31, 2021 | 4.05 Mn |
| Sep 30, 2021 | 5.46 Mn |
| Jun 30, 2021 | 4.60 Mn |
| Mar 31, 2021 | 4.71 Mn |
| Dec 31, 2020 | 3.44 Mn |
| Sep 30, 2020 | 3.04 Mn |
| Jun 30, 2020 | 3.90 Mn |
| Mar 31, 2020 | 5.03 Mn |
| Dec 31, 2019 | 7.57 Mn |
| Sep 30, 2019 | 4.77 Mn |
| Jun 30, 2019 | 5.04 Mn |
| Mar 31, 2019 | 3.11 Mn |